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Clinical experience of magnetic
resonance imaging in patients
with cardiac pacing devices:
unrestricted patient population
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Miia Holmstr€om1, Sari Kivist€o1 and Touko Kaasalainen1
Abstract
Background: Magnetic resonance imaging (MRI) in patients with cardiac pacing devices has become available despite
previously being considered absolutely contraindicated. However, most institutional safety protocols have included
several limitations on patient selection, leaving MRI unavailable for many patients.
Purpose: To evaluate the first 1000 MRI examinations conducted on patients with cardiac pacing devices at  [AQ1]
for any potential safety hazards and also to evaluate the long-term functionality of the safety protocol in “real-life”
clinical practice.
Material and Methods: A total of 1000 clinically indicated MRI scans were performed with a 1.5-T MRI scanner
according to the safety protocol. The following information was collected from the electronic medical record (EMR):
patients’ date of birth; sex; pacing device generator model; date of MRI scan; date of the latest pacing device generator
implantation; and the body region scanned. The EMR of these patients was checked and especially searched for any
pacing device related safety hazards or adverse outcomes during or after the MRI scan.
Results: Only one potentially dangerous adverse event was noted in our study group. In addition, patients with
abandoned leads, temporary pacing devices, and newly implanted pacing device generators were scanned successfully
and safely.
Conclusion: MRI scans can be performed safely in patients with cardiac pacing devices if the dedicated safety protocol
is followed.
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Introduction
The number of patients with cardiac implantable elec-
tronic devices (CIEDs), such as pacemakers (PMs),
implantable cardiac defibrillators (ICDs), and cardiac
resynchronization therapy (CRT) devices, is increasing
rapidly worldwide due to broad indications for pacing
devices and increased life expectancy (1,2). Up to 75%
of those patients are estimated to have a clinical indi-
cation for magnetic resonance imaging (MRI) over the
lifetime of their CIED (3,4).
Previously, cardiac pacing devices have been consid-
ered to be an absolute contraindication for MRI
because of the potential safety concerns related to
interactions of pacing devices and their components
with a strong magnetic field as well as gradient and
radiofrequency fields. These interactions may cause
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an increase of the pacing rate, inhibition of the pacing,
asynchronous pacing, and pacing device reset. The
power-on reset may result in the activation of an inhib-
ited pacing mode instead of programmed asynchronous
pacing. Electromagnetic interference (EMI) could
cause inappropriate inhibition of pacing resulting in
asystole (5–11). In addition, MRI may induce currents
in the pacing leads and discharge heat into the myocar-
dium, leading to myocardial scar tissue, altered capture
thresholds, and therefore impaired function of the
pacing device. Under conventional CIED conditions,
the induced current in the pacing leads is unlikely to
cause myocardial capture, but arrhythmia induction
cannot be excluded (12,13). Recent studies have dem-
onstrated that MRI can be performed safely on
patients with CIED, although some changes in device
parameters have been noted (14–18). However, most
previous studies have included limitations on patients’
pacing device dependency, age of the pacing device, or
body region scanned, and patients with abandoned or
epicardial pacing leads have been excluded (14,15,19).
In addition to the increased use of pacing devices in
patient care, MRI is also increasingly being used, espe-
cially in diagnosing central nervous system, abdominal,
and musculoskeletal disorders, tumors, and some car-
diovascular diseases (20–22). Therefore, it is important
to create a dedicated safety protocol for MRI in
patients with cardiac pacing devices.
The aim of this retrospective study was to evaluate
the first 1000 MRI examinations conducted on patients
with cardiac pacing devices at  [AQ2]for any poten-
tial safety hazards or clinically significant adverse
effects on the pacing devices during or after the MRI
examination, and also to evaluate the long-term func-




The first 1000 clinically indicated MRI examinations
conducted on patients with a cardiac pacing device
performed in  [AQ3]were included in this observa-
tional retrospective study. These examinations were
carried out between November 2011 and April 2017.
One cardiovascular magnetic resonance (CMR) exam-
ination was performed as a part of a clinical study.
One MRI examination was not performed because of
the noise heard from the pacing device when it
entered the magnetic field. This examination was
excluded from the study.
All MRI examinations were performed with a
Siemens Magnetom Avanto 1.5-T scanner that was
updated to Avantofit (both Siemens Healthcare,
Erlangen, Germany) in summer 2013. The Institutional
Review Board of Helsinki University Hospital provided
approval for this retrospective study.
Safety protocol
The MRI examinations of patients with a CIED were
started in [AQ4]in November 2011, according to the
safety protocol developed in close cooperation between
the Department of Cardiology and Department of
Radiology. This safety protocol incorporated
common elements from the previously published pro-
tocols and has been described in detail in a prior pub-
lication (23). The safety protocol has been updated
thereafter according to the lean way of thinking after
practical experiences. The safety protocol is presented
in Figs. 1 and 2 and described below.
The safety protocol involves procedures for MRI
examination in patients with a CIED, including PMs,
ICDs, and CRT devices, both MR-conditional and
MR-unsafe cardiac pacing devices, without limitations
on patients’ pacing dependency or the body region to
be scanned. According to the safety protocol, a radiol-
ogist subspecialized in the field of imaging concerns
evaluates the need for an MRI examination after
receiving the referral for MRI examination from a
requesting physician. If MRI is considered the imaging
method of choice, the MRI examination time is sched-
uled to at least six weeks after the pacing device instal-
lation unless there is an urgent clinical need for an
earlier MRI examination. Patients with an urgent clin-
ical need for an earlier MRI examination are scanned
according to the same safety protocol as other patients.
If the patient has abandoned pacing leads, the cardiol-
ogist evaluates the pacing system compatibility for
MRI beforehand and enters the imaging decision in
the electronic medical record (EMR).
On the day of the MRI examination, before the
scan, the CIED is evaluated and programmed for
MRI by a cardiologist at the PM policlinic or at the
Department of Radiology. During the MRI scan,
patients are monitored with electrocardiography
(ECG) and pulse oximetry. Patients are also monitored
with a camera and asked to report immediately any
torque or heating sensation, pain, palpitation, or any
other unusual symptoms during imaging. In case of an
emergency, a cardiac defibrillator with temporary car-
diac pacing feature is immediately available and the
personnel at the Department of Radiology are trained
to start the resuscitation and to use the defibrillator.
The hospital resuscitation team and a cardiologist are
called by phone and are immediately available. After
the MRI examination, the cardiologist interrogates and
re-programs the pacing device back to its original
2 Acta Radiologica 0(0)
settings at the PM policlinic or at the Department
of Radiology.
The safety protocol has been modified to this form
after some experience of MRI in patients with cardiac
pacing devices. According to the original safety proto-
col, each referral was also evaluated beforehand by a
cardiologist. Currently, this is necessary only when the
patient is known to have any abandoned pacing leads.
In the early phase, the radiologist and physicist were
supervising the MRI examination in addition to the
radiographer performing the MRI scan. In addition,
a cardiologist was present during the MRI scan, when-
ever the cardiac pacing device was not MR-conditional.
After 61 MRI scans without any adverse effects, the
cardiologist was no longer required to be present
during the MRI scan but to be available if requested.
After some more experience in 2016, the radiologist
and physicist were not required to attend the MRI
scan but to be available if requested. A radiologist
has carried a dedicated phone since this decision.
After six months of experience with MRI examina-
tions in patients with pacing devices, the cardiologists
stopped entering the exact measured pacing device
parameters in the EMR; instead, any clinically relevant
changes in the parameters before and after the MRI
examination were briefly described. After 3.5 years of
experience in July 2015, the one-month routine CIED
controls were stopped because no adverse effects on the
pacing devices were detected.
According to the safety protocol, it is also possible
to perform an MRI scan on a patient with CIED in
an emergency case. Most of these scans are performed
during the daytime within regular office hours. If
the patient’s condition is potentially lethal or the
patient is at high risk of being paralyzed and needs
acute treatment, MRI scans can be performed at any
hour. Outside office hours, the senior radiology consul-
tant on duty decides whether an emergency MRI is
the imaging method of choice and is present at the
MR unit until the emergency scan is completed.
Fig. 1. Evaluation before MRI examination.
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Before the MRI examinations, the cardiologist on duty
programs the CIED for MRI, and after the scan, re-
programs the CIED back to its original settings.
Analysis of data
This study was approved by the local institutional review
board. The following information was collected from the
EMR: patients’ date of birth; sex; pacing device generator
model; date of MRI scan; date of the latest pacing device
generator implantation; and the body region scanned.
The EMR of these patients was checked and searched
in particular for any pacing device-related safety hazards
or adverse outcomes during or after the MRI scan, such
as generator failure, power-on reset, clinically relevant
changes in the pacing threshold or sensing that require
system revision or programming changes, unexpected
battery depletion, inhibition of pacing, patient-reported
events, such as discomfort, pain, a warm sensation in the
location of the device, and palpitation. Furthermore, also
the presence of possible abandoned pacing leads was
searched for via the EMR.
Fig. 2. Procedures before, during, and after the MRI examination. AOO/VOO/DOO, asynchronous pacing modes for atrial/ven-
tricular/dual chamber systems, respectively; ECG, electrocardiography; EMR, electronic medical record; IEC, International
Electrotechnical Commission; MR, magnetic resonance; MRI, magnetic resonance imaging; OAO/OVO/ODO, pacing inhibited modes
for atrial/ventricular/dual chamber systems, respectively.
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Data were analyzed with SPSS (released 2013, IBM
SPSS Statistics for Windows, Version 22.0; IBM Corp.,
Armonk, NY, USA).
Results
A total of 1000 MRI examinations were completed on
793 adult patients with a cardiac pacing device
(465 men, 58.6%). The mean age and standard devia-
tion of the patients at the time of MRI examination
was 69.5 14.0 years (age range¼ 18–97 years).
From the first 1000 MRI scans of patients with a
CIED, 869 scans (86.9%) were performed on patients
having a conventional cardiac PM, 61 scans (6.1%) on
patients having an ICD, 39 scans (3.9%) to patients
having a CRT with defibrillator (CRT-D) device, and
31 scans (3.1%) to patients having a CRT with PM
(CRT-P) device (Table 1). Of these, 139/869 (16%),
16/61 (26.2%), 8/39 (20.5%), and 0/31 (0%) examina-
tions were performed on patients carrying an
MR-conditional PM, ICD, CRT-D, or CRT-P
device, respectively. The MRI compatibility data of
two PMs were missing.
All the scanned cardiac pacing devices, except one,
were implanted in 2003 or later and manufactured by
the following companies: St. Jude Medical¼ 56%;
Biotronik¼ 21.4%; Medtronic¼ 15.3%; Boston
Scientific¼ 6.1%; Guidant¼ 0.6%; and Vitatron¼
0.5%. The manufacturer of one PM was missing. One
MRI examination was performed on a patient with a
very old non-adjustable cardiac PM installed in 1986.
Furthermore, the study group contained two patients
with a subcutaneous ICD (S-ICD) device (Boston
Scientific Emblem) and two patients with a leadless
pacing device (Medtronic Micra). One MRI examina-
tion was interrupted because of the noise heard from
the PM when entering the magnetic field (Medtronic
Maximo 2 CRT-D device). In our study population,
one CMR examination was interrupted because of
the artifacts caused by the CRT-D device.
On average, the time from pacing device generator
implantation to the MRI scan was 1180 1002 days.
The date of the generator implantation was missing in
eight cases. The MRI scan was conducted on
24 patients with a newly implanted cardiac pacing
device (<6 weeks, range¼ 0–41 days) due to an
urgent clinical need for the imaging. Eleven of these
patients had a temporary cardiac pacing system with
externalized permanent active-fixation PM lead con-
nected to a permanent PM generator and the generator
was taped onto the chest skin. Six of these “temporary-
permanent” generators were MR-unsafe and the data
related to MRI compatibility were missing in one case.
All these scans were performed without any
adverse events.
Two or more MRI examinations were performed on
151 patients. One patient went through as many as
eight MRI examinations. Ten of these patients had
their pacing device generators changed between the
repeated MRI examinations and one of these patients
had the pacing device generator changed twice between
the examinations. No unexpected battery depletion
after the MRI was detected. The generator changes
were due to an elective replacement time (n¼ 7) or an
infection (n¼ 2). One pacing device generator was
changed due to a back-up mode caused by radiothera-
py. One pacing device generator change was done
because of a device upgrade from a temporary pacing
system to a permanent pacing system.
In 57 MRI examinations, the patients had two body
regions scanned in the same visit. Altogether 1057 body
regions were scanned at 1000 MRI examinations
(Table 2). The spine was the most scanned body
region (n¼ 326, 30.8%), followed by the head
(n¼ 229, 21.7%), abdomen (n¼ 181, 17.1%), and car-
diovascular examination (n¼ 144, 13.6%).
In addition, 22 MRI examinations were completed
of 17 patients with an abandoned pacing lead without
any adverse effects. One of these patients had an aban-
doned epicardial pacing lead that was cut to <5 cm in
length. Two of these patients had two cardiac pacing
devices: one abandoned non-functional pacing system
with leads attached and one fully functional cardiac
pacing device system with leads. All the other aban-
doned pacing leads were capped and without visual
damage on chest X-ray; the insulation of leads was
evaluated to be undamaged.





















PM, pacemaker; ICD, implantable cardiac defibrillator; CRT-D, cardiac
resynchronization therapy with defibrillator; CRT-P, cardiac resynchroni-
zation therapy with pacemaker; MR, magnetic resonance.
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In the 1000 MRI examinations performed, there
was only one potentially dangerous adverse effect on
the pacing device detected. In this case, the PM fell in
to the elective replacement indicator (ERI) mode due to
temporarily programmed high output voltage. As a
consequence, the PM programmed to asynchronous
pacing mode for dual chamber system (DOO) was
changed to ventricular pacing in the inhibited mode
(VVI), which is the inherent ERI mode with this par-
ticular PM model (Medtronic Kappa KSR 401). This
patient was pacing device-dependent. Another patient,
with the Medtronic Kappa KDR 401PM model,
fell into full electrical reset mode with VVI 65/min
pacing mode due to electromagnetic interference.
After the MRI scan, the PM was undamaged and it
was reprogrammed to the previous mode. This patient
was not pacing device-dependent. One patient had a
noise reversion notification during the MRI from the
pacing device system St. Jude Medical Unify Quadra
CD3251-40 Q CRT-D. Noise reversion is an algorithm
that causes the pacing device to automatically change
the pacing mode to asynchronous pacing if it is pro-
grammed to synchronous mode. Noise reversion can be
caused by EMI. The scanning was interrupted for a
moment, the pacing device was re-programmed, and
the scan was completed safely. Three patients reported
subjective symptoms during the MRI scan (feeling ill
after the MRI examination, sensing coldness at the
pacing device generator area, or chest pain), but most
likely these symptoms were not related to the MRI
examination. One S-ICD device’s alarm system was
most likely damaged at MRI. This damage concerns
only the voice of the S-ICD device’s beeper system,
otherwise the alarm system is fully functional and can
be followed remotely. This is an inherent problem with
Boston Scientific ICDs according to vendor informa-
tion (24).
In this study group, 105 (10.5%) emergency MRI
examinations were performed, of which 19 were per-
formed outside regular office hours. All these scans
were completed safely.
Discussion
In this study, we investigated the use of the dedicated
safety protocol for an MRI in patients with a CIED
in a “real-life” setting. Most previous studies on MRI
in patients with a CIED have included limitations on
patients’ pacing device dependency, age of the pacing
device, or body region scanned, and patients with
abandoned or epicardial pacing leads have been
excluded. In the real world, there are many patients
with a CIED who do not meet these criteria but need
an MRI. It is estimated that >8 million people world-
wide have implanted cardiac devices which do not meet
the MR-conditional criteria (11).
According to our large patient dataset and clinical
experience, the MRI examinations can be performed
safely on patients with CIED without limitations on
pacing device type (PM/ICD/CRT-D/CRT-P), pacing
device MRI compatibility (MR-conditional/MR-
unsafe), patients’ pacing device dependency, or the
body region scanned if the dedicated safety protocol
is followed. Our finding is supported by previous stud-
ies (14,15,19,23,25–27). The Heart Rhythm Society
(HRS) published an expert consensus statement on
MRI in patients with CIED in 2017 (28). Our safety
protocol presented here mostly adheres to HRS con-
sensus statement with some minor exceptions. First, we
have scanned also patients with abandoned leads, as
presented in this manuscript. Second, a cardiologist is
not in attendance with pacing device-dependent
patients but immediately available per phone. Third,
the pacing device is checked immediately after the
MRI examination and one year after the MRI examina-
tion, not in 3–6 months after the MRI. The safety pro-
tocol described here was improved and simplified
according to the lean way of thinking after practical expe-
riences. Before the HRS consensus statement was pub-
lished in 2017, our safety protocol in its present form had
been in active use for almost two years without safety
hazards and, in our experience, it is safe and functional.
Currently, MRI scans in patients with cardiac pacing
devices is part of the everyday routine in  [AQ5].
One potentially dangerous adverse event was
noted when a PM (Medtronic Kappa KSR 401) of a
pacing device-dependent patient fell into the ERI
mode. Fortunately, EMI did not cause significant inhi-
bition of pacing during this MRI examination. This
happened in May 2013. The patient was the 63rd
MRI-scanned patient with a CIED in  [AQ6]. This
situation could have probably been avoided with dif-
ferent cardiac pacing device settings. After this inci-
dent, similar situations have not occurred. In
addition, one power-on reset (1/1000, 0.1%) occurred
to a non-pacing-dependent patient with Medtronic
Kappa 401 PM system. In previous studies, the
Table 2. Number of magnetic resonance imaging
examinations performed for different body regions.
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occurrence of power-on resets has been reported to be
0.4–0.6%, which is in line with our results (14,27). In a
prior publication, it was noted that older generation
Medtronic Kappa PMs (market release before 2002)
have a higher risk for power-on reset than other devices
during MRI scan (29). This supports our findings.
In our study group, only one MRI examination was
not performed because of noise heard from the pacing
device when entering the magnetic field. Later on, it
was noted that this is a feature of this CIED model;
later MRI examinations have been completed success-
fully of patients with this particular CIED model
(Medtronic Maximo 2 CRT-D device).
Abandoned pacing leads have been considered to
cause significant risk in MRI on the basis of modeling
studies that found abandoned leads to resonate heat
energy in radiofrequency fields (30). However, in a
recent study, a relatively large number of MRI scans
(n¼ 97) was performed on patients with abandoned
pacing leads without safety hazards (26). A few pub-
lished studies, with a smaller number of patients, on
MRI scans in patients with abandoned pacing leads
have reported similar findings (31–33). In our patient
population, patients with abandoned pacing leads were
scanned successfully and safely when a radiologist con-
sidered MRI necessary and a cardiologist considered
the pacing device system suitable for MRI.
Published institutional safety protocols for MRI in
patients with a CIED include limitations on system
implant duration before MRI. This is due to plausible
lead maturation in a certain time. Occasionally, an
urgent MRI is needed and considered necessary regard-
less of the system implant duration. In our study group,
patients with newly implanted (<6 weeks) pacing
device generators were scanned successfully without
safety hazards. This subgroup included 11 patients
with a temporary pacing system who were also scanned
successfully without adverse events. To our knowledge,
this is the first report regarding MRI examinations per-
formed on patients with an MR-unsafe “temporary-
permanent” pacing system. One case report has been
published of MRI being conducted safely on a patient
after implantation of a “temporary-permanent MR-
conditional” pacing system (34).
The limitations of this study should be considered
carefully. First and foremost, our data did not include
exact pacing device parameters before and after the
MRI examination. Because of the changes made to
the safety protocol in the early phase, only the cardiol-
ogist’s clinical interpretation on parameter changes was
entered in EMR. In previous studies, clinically signifi-
cant changes in cardiac pacing device parameters relat-
ed to MRI have been rare (15,23,25). The data of
patients’ pacing device dependency or the indications
for pacing device implantations were not available.
Therefore, we cannot exactly evaluate whether this
study group represents the whole population of
patients with CIED. A large number of patients in
our study group had a pacing device system that had
been originally implanted before the EMR was used in
our hospital and the data of the electrode models were
not available. Due to this lacking information, we cat-
egorized pacing devices only according to the pacing
devices’ generator model to MR-conditional and
MR-unsafe devices. This safety protocol has no limita-
tions on pacing device dependency or body region
scanned; almost all patients referred for MRI were
scanned. However, some patients with visually dam-
aged uncapped leads were not scanned. Almost all
CIEDs scanned in our study group were implanted in
the year 2003 or after and the results cannot be directly
extrapolated to older CIED models. In this study, only
a 1.5-T magnetic field strength was used.
In conclusion, if MRI examinations in patients with
cardiac pacing devices are performed in a controlled
and monitored environment, these can be conducted
safely also in an unrestricted patient population,
including pacing-dependent patients and patients with
MR-unsafe cardiac pacing devices.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of
this article.
Funding
This research received no specific grant from any funding




1. John Camm A, Nisam S. European utilization of the
implantable defibrillator: has 10 years changed the
‘enigma’? Europace 2010;12:1063–1069.
2. Kremers MS, Hammill SC, Berul CI, et al. The National
ICD Registry Report: version 2.1 including leads and
pediatrics for years 2010 and 2011. Heart Rhythm
2013;10:e59–e65.
3. Kalin R, Stanton MS. Current clinical issues for MRI
scanning of pacemaker and defibrillator patients.
Pacing Clin Electrophysiol 2005;28:326–328.
4. Nazarian S, Reynolds MR, Ryan MP, et al. Utilization
and likelihood of radiologic diagnostic imaging in
patients with implantable cardiac defibrillators. J Magn
Reson Imaging 2016;43:115–127.
Vuorinen et al. 7
5. Irnich W, Irnich B, Bartsch C, et al. Do we need pace-
makers resistant to magnetic resonance imaging?
Europace 2005;7:353–365.
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